BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16331486)

  • 1. A new treatment regimen in combined intravitreal injection of triamcinolone acetonide and photodynamic therapy.
    Krebs I; Binder S; Stolba U
    Graefes Arch Clin Exp Ophthalmol; 2006 Jul; 244(7):863-7. PubMed ID: 16331486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone acetonide or intravitreal bevacizumab on choroidal hypofluorescence by indocyanine green angiography.
    Hatta Y; Ishikawa K; Nishihara H; Ozawa S; Ito Y; Terasaki H
    Retina; 2010 Mar; 30(3):495-502. PubMed ID: 19996828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal angiomatous proliferation: combined therapy of intravitreal triamcinolone acetonide and PDT versus PDT alone.
    Krebs I; Krepler K; Stolba U; Goll A; Binder S
    Graefes Arch Clin Exp Ophthalmol; 2008 Feb; 246(2):237-43. PubMed ID: 17674018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
    Spaide RF; Sorenson J; Maranan L
    Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal angiomatous proliferation treated with a combination of intravitreal triamcinolone acetonide and photodynamic therapy with verteporfin.
    Mantel I; Ambresin A; Zografos L
    Eur J Ophthalmol; 2006; 16(5):705-10. PubMed ID: 17061221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.
    Spaide RF; Sorenson J; Maranan L
    Ophthalmology; 2005 Feb; 112(2):301-4. PubMed ID: 15691567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation.
    Freund KB; Klais CM; Eandi CM; Ober MD; Goldberg DE; Sorenson JA; Yannuzzi LA
    Arch Ophthalmol; 2006 Apr; 124(4):487-92. PubMed ID: 16606873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indocyanine green-mediated photothrombosis with intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization in age-related macular degeneration.
    Arevalo JF; Garcia RA; Mendoza AJ
    Graefes Arch Clin Exp Ophthalmol; 2005 Nov; 243(11):1180-5. PubMed ID: 15906068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcome.
    Ruiz-Moreno JM; Montero JA; Barile S; Zarbin MA
    Retina; 2006; 26(6):602-12. PubMed ID: 16829800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of intravitreal triamcinolone acetonide with photodynamic therapy and intravitreal bevacizumab with photodynamic therapy for retinal angiomatous proliferation.
    Saito M; Shiragami C; Shiraga F; Kano M; Iida T
    Am J Ophthalmol; 2010 Mar; 149(3):472-81.e1. PubMed ID: 20053392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study.
    Weigert G; Michels S; Sacu S; Varga A; Prager F; Geitzenauer W; Schmidt-Erfurth U
    Br J Ophthalmol; 2008 Mar; 92(3):356-60. PubMed ID: 18303156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
    Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
    Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of photodynamic therapy and intraocular triamcinolone for exudative age-related macular degeneration and long-term chorioretinal macular atrophy.
    Piermarocchi S; Sartore M; Lo Giudice G; Maritan V; Midena E; Segato T
    Arch Ophthalmol; 2008 Oct; 126(10):1367-74. PubMed ID: 18852414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy combined with low-dose intravitreal triamcinolone acetonide for age-related macular degeneration refractory to photodynamic therapy alone.
    Iwama D; Otani A; Sasahara M; Yodoi Y; Gotoh N; Tamura H; Tsujikawa A; Yoshimura N
    Br J Ophthalmol; 2008 Oct; 92(10):1352-6. PubMed ID: 18662914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of posterior juxtascleral triamcinolone acetonide on the efficacy and choriocapillaris hypoperfusion of photodynamic therapy.
    Iriyama A; Obata R; Inoue Y; Takahashi H; Tamaki Y; Yanagi Y
    Graefes Arch Clin Exp Ophthalmol; 2008 Mar; 246(3):339-44. PubMed ID: 17805556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.
    Chaudhary V; Mao A; Hooper PL; Sheidow TG
    Ophthalmology; 2007 Dec; 114(12):2183-9. PubMed ID: 18054638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.
    Arias L; Garcia-Arumi J; Ramon JM; Badia M; Rubio M; Pujol O
    Ophthalmology; 2006 Dec; 113(12):2243-50. PubMed ID: 16996600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
    Jonas JB; Kreissig I; Kamppeter B; Degenring RF
    Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined photodynamic therapy and intravitreal triamcinolone acetonide injection for neovascular age-related macular degeneration with pigment epithelium detachment.
    Axer-Siegel R; Ehrlich R; Avisar I; Kramer M; Rosenblatt I; Priel E; Weinberger D
    Ophthalmic Surg Lasers Imaging; 2006; 37(6):455-61. PubMed ID: 17152538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
    Augustin AJ; Schmidt-Erfurth U
    Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.